Accelerate small molecule discovery for immune diseases using an AI-driven platform that integrates automated chemical synthesis and predictive molecular design.
Discover 5 Drug Development tools on AI Tech Suite, including DeepCure, Pathos AI and X37
Accelerate small molecule discovery for immune diseases using an AI-driven platform that integrates automated chemical synthesis and predictive molecular design.
Pathos AI uses AI to accelerate drug development by optimizing patient selection, biomarker development, and clinical trial design, focusing on precision medicine.
Accelerate therapeutic discovery for researchers by leveraging AI to target difficult-to-drug proteins across cancer, autoimmune diseases, and anticoagulation.
Accelerate immunotherapy development and reduce costs through AI-powered target identification and predictive modeling for more precise oncology treatments.
Optimize drug development timelines and clinical pharmacology decisions using an AI-powered platform for advanced modeling and regulatory submission success.